Melanotan I
Peptide therapy: benefits, side effects, cost and protocols
Melanotan I (afamelanotide) is a synthetic analog of alpha-melanocyte-stimulating hormone developed for skin tanning. It is available as a prescription drug (Scenesse) for certain light-related skin conditions and studied as a preventative agent for skin cancer in patients with photosensitivity disorders.
Sources: FDA / PubMed / ClinicalTrials.gov View
Spec sheet
- FDA status
- Research Only Not currently approved for human use in the US. Available as a research compound. Not eligible for compounding.
- Evidence
- Moderate Evidence
Who it's for
Who Melanotan I is usually considered for
- Tanning research
- Melanin production
- Skin protection research
- Limited human trials or strong preclinical
Mechanism
How Melanotan I works
Selective melanocortin-1 receptor agonist that promotes melanin production without significant effects on other melanocortin pathways.
Evidence
Key studies
241 papers on PubMed
- 01
Skin pigmentation and pharmacokinetics of melanotan-I in humans
- 02
Ugwu SO, Blanchard J, Dorr RT et al
Biopharm Drug Dispos / Biopharm Drug Dispos / Phase 1
Subcutaneous melanotan-I administration achieved complete bioavailability with significant tanning effects lasting 3 weeks post-treatment.
- 03
Subcutaneous melanotan-I administration achieved complete bioavailability with significant tanning effects lasting 3 weeks post-treatment
- 04
A glimpse into the underground market of melanotan
Dermatol Online J / Dermatol Online J
- 05
Online survey of melanotan users examining motivations, barriers, and plans for continued use of illicit melanotropic peptides
- 06
Increased eumelanin expression and tanning is induced by a superpotent melanotropin [Nle4-D-Phe7]-alpha-MSH in humans
- 07
Dorr RT, Dvorakova K, Brooks C et al
Case Series / Photochem Photobiol / Phase 1
Melanotan-I induced tanning with 49-98% increase in skin eumelanin content.
- 08
Melanotan-I induced tanning with 49-98% increase in skin eumelanin content
- 09
Melanotan II injection resulting in systemic toxicity and rhabdomyolysis
Case Series / Clin Toxicol (Phila)
- 10
Melanotan II overdose caused sympathomimetic toxicity, rhabdomyolysis, and acute kidney injury
FAQ
Melanotan I questions
What is MELANOTAN I?
Melanotan I (Afamelanotide) is a melanocortin peptide primarily researched for its tanning effects, with a more selective receptor profile than Melanotan II.
How does MELANOTAN I work?
Selective melanocortin-1 receptor agonist that promotes melanin production without significant effects on other melanocortin pathways.
Is MELANOTAN I legal to buy?
MELANOTAN I is sold as a research chemical for laboratory use only. It is not approved for human use by the FDA. Regulations vary by jurisdiction.
Where can I buy MELANOTAN I?
MELANOTAN I is available as a research compound from verified online vendors. Always verify third-party testing before purchasing.
What category does MELANOTAN I belong to?
MELANOTAN I is primarily classified as a skin, hair & cosmetic peptide. Peptides studied for cosmetic applications including skin rejuvenation, collagen production, tanning, hair growth, and anti-wrinkle effects.
What are the research benefits of MELANOTAN I?
MELANOTAN I has been studied for: Tanning research, Melanin production, Skin protection research. Melanotan variant; more selective than MT-II.
News
Melanotan I in the news
Man Injects Gym-Bought Tanning Peptide, Gets a New Melanoma - Gizmodo
Gizmodo / 2 days ago
The Skin Cancer Foundation Issues Warning Regarding Melanotan II - The Skin Cancer Foundation
The Skin Cancer Foundation / 3 months ago
The Peptide Craze Is Coming for Your Skin. What to Know about the ‘Barbie Peptide’ People Are Taking to Get Tan. - Women's Health
Women's Health / 3 months ago
Melanotan Exposed: Facts, Fiction, and Safety Concerns - The Dermatology Digest
The Dermatology Digest / 3 months ago
Tanning Influencers Push ‘Barbie Peptide.’ Here Are Risks Of Melanotan - Forbes
Forbes / 2 months ago
News aggregated via Google News. Inclusion does not imply endorsement.
Considering Melanotan I?
The 2-minute quiz matches you with licensed providers who offer it. A clinician decides if it fits.